Chiaki Saita Risa Goto Tomoyuki Aruga Nami Idera Yayoi Honda Kazumi Horiguchi Hiromi Miyamoto Shinichiro Horiguchi Toshinari Yamashita Katsumasa Kuroi
10.1186/s13104-016-1854-4
BMC Res Notes
2016 Jan 26;9:46.
CC BY
https://pubmed.ncbi.nlm.nih.gov/26813772/
Antineoplastic Agents, Hormonal / therapeutic use Aromatase Inhibitors / therapeutic use Breast Neoplasms / therapy Carcinoma, Papillary / therapy Nitriles / therapeutic use Triazoles / therapeutic use
Antineoplastic Agents, Hormonal / therapeutic use Aromatase Inhibitors / therapeutic use Breast Neoplasms / therapy Carcinoma, Papillary / therapy Nitriles / therapeutic use Triazoles / therapeutic use Case Reports Aged, 80 and over Breast Neoplasms / genetics Breast Neoplasms / metabolism Breast Neoplasms / pathology Carcinoma, Papillary / genetics Carcinoma, Papillary / metabolism Carcinoma, Papillary / pathology Female Gene Expression Humans Letrozole Neoadjuvant Therapy / methods Postmenopause Receptor, ErbB-2 / genetics Receptor, ErbB-2 / metabolism Receptors, Estrogen / genetics Receptors, Estrogen / metabolism Receptors, Progesterone / genetics Receptors, Progesterone / metabolism Treatment Outcome Antineoplastic Agents, Hormonal Aromatase Inhibitors Nitriles Receptors, Estrogen Receptors, Progesterone Triazoles Letrozole ERBB2 protein, human Receptor, ErbB-2
PMC4727271
26813772
Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved
2016